BioAdaptives, Inc. announced the appointment of Dr. Yaguang Liu to its Board of Directors. Yaguang Liu is the founder of L.Y. Research Corporation located in New Jersey. He has received 32U.S. patents of pure and safe natural botanicals, used for treatment of cancer and cardiovascular and other diseases.

Dr. Liu has extensive experience in dealing with the U.S. FDA in the IND application process, clinical studies and the whole process of developing new drugs, including botanical drugs in the United States. This highlights Dr. Liu's genius ability to identify active ingredients in botanicals. He also has close contacts with major U.S. research institutions and pharmaceutical companies.

Dr. Liu was born and educated in the People's Republic of China. He graduated from Fudan University, Shanghai and had been a visiting Professor at the Department of Medicine of the University of Chicago. He established the Molecular Medicine Institute in China and was a director of this institute.

He has authored four books: (1) An Investigation of the Combined Theories of Chinese and Western Medicines from the Angle of Molecular Biology; (2) Molecular Biology in Heart Disease; (3) Principles of Theoretical Medicine; and (4) Natural Science and the Theory of Chinese Medicine. He has published scientific papers in several national and international medical and pharmaceutical meetings, including annual Scientific Meeting of the American Society (San Diego, U.S.), of (Victoria, Australia), American Chemical Society Meeting (Boston, U.S.), Conference of the American Association for Cancer Research and the Japanese Cancer Association (Hawaii, U.S.).